{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:52:59Z","timestamp":1795024379812,"version":"4.10.2"},"reference-count":0,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Gastroenterol"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Background\u2002Virologic failure to approved combinations of direct antiviral agents (DAA) in patients with chronic hepatitis C virus (HCV) infection is rare. Mostly it involves difficult to treat patients with advanced liver disease and prior interferon-experience. Before approval of VOX\/VEL\/SOF, a restricted number of patients received rescue treatment, and the choice of DAA combinations for re-treatment were selected on an individual basis. In the present analysis, patient characteristics and rescue-regimens after virologic failure mainly based on first generation DAAs are described.<\/jats:p><jats:p>\n          Patients and methods\u2002Data were obtained from the German Hepatitis C-Registry (DHC-R), which is a national multicenter real-world cohort currently including about 16\u200a500 patients recruited by more than 250 centers. The present analysis is based on 6683 patients who initiated a DAA therapy and for whom follow-up data (per-protocol analysis) were available.<\/jats:p><jats:p>\n          Results\u2002Among the patients, 188 (2.8\u200a%) experienced a virologic relapse. Compared to SVR-patients, relapse patients were significantly more often male (77.7\u200a% versus 56.9\u200a%, respectively, p\u200a&lt;\u200a0.001), showed cirrhosis significantly more (48.4\u200a% versus 28.1\u200a%, respectively, p\u200a&lt;\u200a0.001) and a prior interferon-containing therapy (46.3\u200a% versus 39.0\u200a%, respectively, p\u200a=\u200a0.049). The majority of patients who relapsed were infected with genotype 1 (47.4\u200a%) followed by genotype 3 (29.8\u200a%), and 95 relapse patients started DAA re-treatment. Characteristics of patients with rescue-treatment are similar to these of patients with relapse after initial DAA treatment. Thirty-one of 39 patients with complete follow-up data achieved SVR (79.5\u200a%), and 8 patients had a relapse again (20.5\u200a%). Patients who received rescue treatment including a new DAA class according to guidelines, except patients who received VOX\/VEL\/SOF, showed higher SVR rates than the entire group (21\/25, 84\u200a%). All patients who received VOX\/VEL\/SOF achieved SVR (n\u200a=\u200a4, 100\u200a%).<\/jats:p><jats:p>\n          Conclusions\u2002Patients with failure with DAA combination therapies are a difficult but urgent to treat population with the frequent presence of cirrhosis and prior treatment failure with interferon-based therapies. Rescue therapy with inclusion of a new DAA class leads to high SVR rates, but multiple targeted therapy with VOX\/VEL\/SOF seems to be most effective.<\/jats:p>","DOI":"10.1055\/a-1068-3056","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:06:30Z","timestamp":1581379590000},"page":"341-351","source":"Crossref","is-referenced-by-count":9,"title":["Treatment-failure to direct antiviral HCV regimens in real world: frequency, patient characteristics and rescue therapy \u2013 data from the\u00a0German hepatitis C registry (DHC-R)"],"prefix":"10.1055","volume":"58","author":[{"given":"Annika","family":"Schmitt","sequence":"additional","affiliation":[{"name":"St. Josefs-Hospital, Wiesbaden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"G\u00fcnther","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinikum Schleswig-Holstein (UKSH), Campus Kiel, Kiel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Mauss","sequence":"additional","affiliation":[{"name":"Center for HIV and Hepatogastroenterology, D\u00fcsseldorf"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus H. W.","family":"Boeker","sequence":"additional","affiliation":[{"name":"Hepatologische Praxis, Hannover"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Buggisch","sequence":"additional","affiliation":[{"name":"ifi-Institut f\u00fcr interdisziplin\u00e4re Medizin, Hamburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"Hillenbrand","sequence":"additional","affiliation":[{"name":"Praxis City Ost, Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"John","sequence":"additional","affiliation":[{"name":"Internistische Arztpraxis, Berlin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartwig","family":"Klinker","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinikum W\u00fcrzburg, W\u00fcrzburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Pathil","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinkium Heidelberg, Heidelberg"},{"name":"Universit\u00e4tsklinikum Frankfurt, Frankfurt am Main"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Georg","family":"Simon","sequence":"additional","affiliation":[{"name":"MVZ Dres. Eisenbach, Simon, Schwarz GbR, Leverkusen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Serfert","sequence":"additional","affiliation":[{"name":"Leberstiftungs-GmbH Deutschland, Hannover"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Niederau","sequence":"additional","affiliation":[{"name":"St. Josef-Hospital, Katholisches Klinikum Oberhausen, Oberhausen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Vermehren","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinikum Frankfurt, Frankfurt am Main"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[{"name":"Leberstiftungs-GmbH Deutschland, Hannover"},{"name":"Universit\u00e4tsklinikum Essen, Universit\u00e4t Duisburg-Essen, Essen"},{"name":"Medizinische Hochschule Hannover, Hannover"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Sarrazin","sequence":"additional","affiliation":[{"name":"St. Josefs-Hospital, Wiesbaden"},{"name":"Universit\u00e4tsklinikum Frankfurt, Frankfurt am Main"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2020,2,10]]},"container-title":["Zeitschrift f\u00fcr Gastroenterologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1068-3056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T12:59:09Z","timestamp":1588683549000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1068-3056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":0,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2020,4,30]]},"published-print":{"date-parts":[[2020,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1068-3056","relation":{},"ISSN":["0044-2771","1439-7803"],"issn-type":[{"value":"0044-2771","type":"print"},{"value":"1439-7803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]}}}